×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PVLA – palvella therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PVLA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/4
08:00 am
pvla
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
High
Report
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
4/2
08:00 am
pvla
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
High
Report
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
4/1
08:00 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
High
Report
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
3/31
07:30 am
pvla
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Low
Report
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
3/26
08:14 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
3/26
06:22 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
3/25
08:40 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Jones Trading. They set a "buy" rating and a $45.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Jones Trading. They set a "buy" rating and a $45.00 price target on the stock.
3/18
08:30 am
pvla
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
Medium
Report
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: